A growing number of Spokane-area women who are at high risk for inherited breast or ovarian cancer are turning to their genes for answers, in the hope that what they find might save a life - their own or a

SAN DIEGO -- Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit today presented findings showing that adding curcumin or resveratrol to conventional chemotherapy could be effective in preventing the growth of chemo-resistant colon cancer cells. The poster presentation

SAN DIEGO -- BiPar Sciences, Inc. today announced positive preclinical data demonstrating the activity of its lead poly ADP-ribose polymerase (PARP) inhibitor, BSI-201, in ovarian cancer models. The results highlight the anti-tumor activity of BSI-201 through PARP activity inhibition, tumor

The adequacy of laparoscopic-assisted colectomy (LAC) for colon cancer has been heavily scrutinized, causing most surgeons to await survival data before undertaking laparoscopic resection for malignancy. However, encouraging results published by Lacy et al. in 2002(1) included experienced laparoscopic surgeons

WILMINGTON, Mass. -- Sirtex, a leading developer of targeted and innovative cancer therapies, has received FDA approval under Investigational Device Exemption to conduct the first clinical trial to evaluate the safety of concurrent administration of FOLFOX6 and bevacizumab, an anti-angiogenic,

Incorporating genetic information known as gene expression signatures with clinical and other risk factors for breast cancer may help refine estimates of relapse-free survival and predicted response to chemotherapy, according to a study in the April 2 issue of JAMA."The

New studies at the University of Adelaide, Australia, will delve into some of the crucial issues surrounding death by brain tumours and stroke. The research, to be conducted in the joint University of Adelaide/IMVS Centre for Neurological Diseases, will aim

NUTLEY, N.J. -- A novel biweekly dosing schedule of Xeloda(R) (capecitabine) enabled safe delivery of higher daily doses in the treatment of advanced breast cancer, according to an investigational study published in the April 10, 2008 issue of the Journal

REYKJAVIK, Iceland -- Scientists in Iceland said they have found a fourth set of genetic variants linked to an increased risk of estrogen receptor-positive breast cancer. The findings, published in the journal Nature genetics, are being used to develop a